Data month 2026-07
According to AlphaMoat, in 2026-07 menten.AI (menten.ai) received 0 monthly visits (-100% MoM) — ranked #0 of 17,407 AI websites with traffic data, and #0 of 3,173 in Industry Services; its largest market is United States (52.9% of visits).
Monthly Visits · 2026-07
--100%
Overall Rank (17,407)
-
Industry Services Rank (3,173)
-
Top Market
United States52.9%
What is menten.AI
Product Overview
Menten AI is a company using generative AI for peptide drug design; its MAUD 1.0 platform rapidly creates macrocyclic peptides with oral bioavailability and cell permeability, partnering with the world's top 10 pharma companies.
Key Features6 items
- 01Design drug-like macrocyclic peptides with generative AI
- 02rapidly create candidate molecules via the MAUD 1.0 platform
- 03optimize oral bioavailability and cell permeability
- 04offer new chemistry paradigms for hard targets
- 05advance with top 10 global pharma
- 06cover from discovery to process
12-Month Traffic Trend
Hover for monthly values
Latest -MoM-100%YoY+41.7%
2025-08
2.2K
+49.9%
2025-09
1.6K
-26.7%
2025-10
1.8K
+11.2%
2025-11
2.1K
+16.1%
2025-12
2.2K
+4.4%
2026-01
890
-59.6%
2026-02
1.5K
+71.2%
2026-03
2.0K
+31.2%
2026-04
3.8K
+92.3%
2026-05
3.4K
-12.0%
2026-06
1.5K
-56.7%
2026-07
2.1K
+43.8%
Visits by Country · Top 5
2026-07 · Share of total visits
United States
1,11552.9%
India
99247.1%
Popular in Industry Services
Click for details, or "+ Compare" to compare with menten.AI
Data month: 2026-07 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.